These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 12488239)
1. Selective effects of serotonergic psychoactive agents on gastrointestinal functions in health. Chial HJ; Camilleri M; Burton D; Thomforde G; Olden KW; Stephens D Am J Physiol Gastrointest Liver Physiol; 2003 Jan; 284(1):G130-7. PubMed ID: 12488239 [TBL] [Abstract][Full Text] [Related]
2. Effects of venlafaxine, buspirone, and placebo on colonic sensorimotor functions in healthy humans. Chial HJ; Camilleri M; Ferber I; Delgado-Aros S; Burton D; McKinzie S; Zinsmeister AR Clin Gastroenterol Hepatol; 2003 May; 1(3):211-8. PubMed ID: 15017493 [TBL] [Abstract][Full Text] [Related]
3. Effects of different doses of venlafaxine on serotonin and norepinephrine reuptake in healthy volunteers. Blier P; Saint-André E; Hébert C; de Montigny C; Lavoie N; Debonnel G Int J Neuropsychopharmacol; 2007 Feb; 10(1):41-50. PubMed ID: 16690005 [TBL] [Abstract][Full Text] [Related]
4. Venlafaxine extended-release: a review of its use in the management of major depression. Wellington K; Perry CM CNS Drugs; 2001; 15(8):643-69. PubMed ID: 11524036 [TBL] [Abstract][Full Text] [Related]
5. A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Richard IH; McDermott MP; Kurlan R; Lyness JM; Como PG; Pearson N; Factor SA; Juncos J; Serrano Ramos C; Brodsky M; Manning C; Marsh L; Shulman L; Fernandez HH; Black KJ; Panisset M; Christine CW; Jiang W; Singer C; Horn S; Pfeiffer R; Rottenberg D; Slevin J; Elmer L; Press D; Hyson HC; McDonald W; Neurology; 2012 Apr; 78(16):1229-36. PubMed ID: 22496199 [TBL] [Abstract][Full Text] [Related]
6. Pattern of symptom improvement following treatment with venlafaxine XR in patients with generalized anxiety disorder. Meoni P; Salinas E; Brault Y; Hackett D J Clin Psychiatry; 2001 Nov; 62(11):888-93. PubMed ID: 11775049 [TBL] [Abstract][Full Text] [Related]
7. Double-blind, randomized, placebo-controlled study to evaluate the effects of tegaserod on gastric motor, sensory and myoelectric function in healthy volunteers. Talley NJ; Camilleri M; Burton D; Thomforde G; Koch K; Rucker MJ; Peterson J; Zinsmeister AR; Earnest DL Aliment Pharmacol Ther; 2006 Sep; 24(5):859-67. PubMed ID: 16918891 [TBL] [Abstract][Full Text] [Related]
8. [Combination of serotonergic agents resulted in severe adverse effects]. Jägestedt M; von Bahr C Lakartidningen; 2004 Apr; 101(18):1618-9. PubMed ID: 15185539 [TBL] [Abstract][Full Text] [Related]
9. Efficacy screening trials of paroxetine, pentoxifylline, riluzole, pramipexole and venlafaxine in cocaine dependence. Ciraulo DA; Sarid-Segal O; Knapp CM; Ciraulo AM; LoCastro J; Bloch DA; Montgomery MA; Leiderman DB; Elkashef A Addiction; 2005 Mar; 100 Suppl 1():12-22. PubMed ID: 15730346 [TBL] [Abstract][Full Text] [Related]
10. Prucalopride accelerates gastrointestinal and colonic transit in patients with constipation without a rectal evacuation disorder. Bouras EP; Camilleri M; Burton DD; Thomforde G; McKinzie S; Zinsmeister AR Gastroenterology; 2001 Feb; 120(2):354-60. PubMed ID: 11159875 [TBL] [Abstract][Full Text] [Related]
11. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Degen L; Matzinger D; Merz M; Appel-Dingemanse S; Osborne S; Lüchinger S; Bertold R; Maecke H; Beglinger C Aliment Pharmacol Ther; 2001 Nov; 15(11):1745-51. PubMed ID: 11683688 [TBL] [Abstract][Full Text] [Related]
12. A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder. Pollack M; Mangano R; Entsuah R; Tzanis E; Simon NM; Zhang Y Psychopharmacology (Berl); 2007 Oct; 194(2):233-42. PubMed ID: 17589833 [TBL] [Abstract][Full Text] [Related]
13. Differential physiological effects of a low dose and high doses of venlafaxine in major depression. Debonnel G; Saint-André E; Hébert C; de Montigny C; Lavoie N; Blier P Int J Neuropsychopharmacol; 2007 Feb; 10(1):51-61. PubMed ID: 16690006 [TBL] [Abstract][Full Text] [Related]
14. A double-blind, randomized, placebo-controlled trial of itopride (100 and 200 mg three times daily) on gastric motor and sensory function in healthy volunteers. Choung RS; Talley NJ; Peterson J; Camilleri M; Burton D; Harmsen WS; Zinsmeister AR Neurogastroenterol Motil; 2007 Mar; 19(3):180-7. PubMed ID: 17300287 [TBL] [Abstract][Full Text] [Related]
15. Effects of paroxetine and venlafaxine XR on heart rate variability in depression. Davidson J; Watkins L; Owens M; Krulewicz S; Connor K; Carpenter D; Krishnan R; Nemeroff C J Clin Psychopharmacol; 2005 Oct; 25(5):480-4. PubMed ID: 16160626 [TBL] [Abstract][Full Text] [Related]
16. Estimates of serotonin and norepinephrine transporter inhibition in depressed patients treated with paroxetine or venlafaxine. Owens MJ; Krulewicz S; Simon JS; Sheehan DV; Thase ME; Carpenter DJ; Plott SJ; Nemeroff CB Neuropsychopharmacology; 2008 Dec; 33(13):3201-12. PubMed ID: 18418363 [TBL] [Abstract][Full Text] [Related]
17. Effects on gastrointestinal functions and symptoms of serotonergic psychoactive agents used in functional gastrointestinal diseases. Grover M; Camilleri M J Gastroenterol; 2013 Feb; 48(2):177-81. PubMed ID: 23254779 [TBL] [Abstract][Full Text] [Related]
18. Effect of a glucagon-like peptide 1 analog, ROSE-010, on GI motor functions in female patients with constipation-predominant irritable bowel syndrome. Camilleri M; Vazquez-Roque M; Iturrino J; Boldingh A; Burton D; McKinzie S; Wong BS; Rao AS; Kenny E; Månsson M; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2012 Jul; 303(1):G120-8. PubMed ID: 22517769 [TBL] [Abstract][Full Text] [Related]
19. Effect of a selective chloride channel activator, lubiprostone, on gastrointestinal transit, gastric sensory, and motor functions in healthy volunteers. Camilleri M; Bharucha AE; Ueno R; Burton D; Thomforde GM; Baxter K; McKinzie S; Zinsmeister AR Am J Physiol Gastrointest Liver Physiol; 2006 May; 290(5):G942-7. PubMed ID: 16603730 [TBL] [Abstract][Full Text] [Related]
20. Acute effects of venlafaxine and paroxetine on serotonergic transmission in human volunteers. Porter RJ; McAllister-Williams RH; Young AH Psychopharmacology (Berl); 1999 Sep; 146(2):194-8. PubMed ID: 10525755 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]